Medically reviewed by Dr. Tom Biernacki, DPM — Board-Certified Podiatric Surgeon — Balance Foot & Ankle, Howell & Bloomfield Hills, MI. Last updated April 2026.

What Is Charcot Foot? For specialized treatment, see our Charcot foot treatment Michigan.

Charcot foot (Charcot neuroarthropathy) is a severe, limb-threatening complication of peripheral neuropathy—most commonly diabetic neuropathy—in which progressive destruction of the bones, joints, and soft tissues of the foot and ankle occurs due to repetitive microtrauma that the patient cannot feel. Because neuropathy eliminates the pain signal that normally limits activity after injury, patients continue walking on fractures and dislocations, causing progressive destruction. Left untreated, Charcot foot produces catastrophic deformity—the foot collapses into a “rocker bottom” shape—creating plantar prominences that ulcerate and lead to osteomyelitis and amputation. Early recognition and off-loading are critical to prevent irreversible deformity.

Who Gets Charcot Foot?

Charcot neuroarthropathy affects patients with severe peripheral neuropathy from any cause, but diabetic neuropathy accounts for the vast majority of cases. It is estimated to affect 0.5–2.5% of diabetic patients with neuropathy, with higher rates in patients with longer duration of diabetes and poorer glucose control. Risk factors include: long-standing diabetes (typically more than 10 years), severe peripheral neuropathy (absent protective sensation), history of foot trauma or surgery, and intact circulation (paradoxically, patients need adequate blood flow to develop the inflammatory bone response that drives Charcot changes). Charcot does not occur in patients with severe vascular disease because the hyperemic response requires adequate perfusion.

Early Warning Signs: The Acute Phase

The acute (active) Charcot phase presents with a hot, swollen, red foot that may closely mimic cellulitis, deep vein thrombosis, or gout. The foot is dramatically warmer than the contralateral foot—typically 3–7°C warmer by infrared thermometry. Crucially, pain is minimal or absent due to neuropathy, which is the hallmark that distinguishes Charcot from infection or thrombosis in a neuropathic patient. The patient may report only mild discomfort, swelling, or redness without a preceding injury they can recall. Any diabetic patient with a warm, swollen foot and neuropathy must be assumed to have Charcot neuroarthropathy until proven otherwise—delayed diagnosis is the most common and devastating error in management.

Stages of Charcot Foot (Eichenholtz Classification)

Stage 0 (prodromal): Foot warm and swollen with normal X-rays. MRI shows bone marrow edema. Stage I (active/fragmentation): X-rays show fracture, dislocation, and bone fragmentation. The foot is severely inflamed. Stage II (coalescence): Inflammation begins to subside; fractures show early healing; bone fragmentation reduces. Stage III (consolidation/reconstruction): Inflammation resolved; foot deformity has developed; bones remodel into a stable (though often severely deformed) configuration. The goal of treatment is to reach Stage III with the minimum possible deformity.

Treatment: Off-Loading Is Everything

The cornerstone of Charcot treatment is immediate, complete off-loading of the foot. A total contact cast (TCC) is the gold standard—a custom-molded, non-removable cast that distributes plantar pressure over the entire foot, preventing all focused loading. The critical principle: the cast must be non-removable, because patients with neuropathy cannot be relied upon to remain non-weight-bearing even with removable devices. Total contact casting continues until the acute phase resolves (skin temperature normalizes, swelling decreases)—typically 3–6 months. The patient then transitions to a Charcot Restraint Orthotic Walker (CROW) or custom diabetic footwear to maintain protection during the consolidation phase.

Surgical reconstruction may be required when Charcot produces a deformity so severe that no accommodative footwear can adequately protect the foot from ulceration—particularly the “rocker bottom” foot with a prominent plantar midfoot. Surgical reconstruction (superconstructs with intramedullary beaming and external fixation) restores a plantigrade, stable foot. Surgery in Charcot carries high complication rates and is reserved for patients where the alternative is amputation.

Frequently Asked Questions

Medical References & Sources

• PubMed Research — Charcot Neuroarthropathy Treatment
• PubMed Research — Charcot Foot Surgical Reconstruction
• American Podiatric Medical Association — Charcot Foot

Dr. Tom Biernacki, DPM is a board-certified podiatric surgeon at Balance Foot & Ankle in Howell and Bloomfield Hills, Michigan. He specializes in diabetic foot care including Charcot neuroarthropathy recognition, total contact casting, and surgical reconstruction for limb preservation.

Sources

1. Rogers LC et al. “The Charcot foot in diabetes.” Diabetes Care. 2011;34(9):2123-2129.
2. Frykberg RG, Belczyk R. “Epidemiology of the Charcot foot.” Clin Podiatr Med Surg. 2008;25(1):17-28.
3. Wukich DK, Sung W. “Charcot arthropathy of the foot and ankle: modern concepts and management review.” J Diabetes Complications. 2009;23(6):409-426.

Dr. Tom Biernacki, DPM

Dr. Tom Biernacki, DPM is a double board-certified podiatrist and foot & ankle surgeon at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has reached over one million views.